Free Trial

GENMAB A/S/S (GMXAY) News Today

$28.20
+0.21 (+0.75%)
(As of 05/31/2024 ET)
Decoding 9 Analyst Evaluations For Genmab
Earnings Preview For Genmab
Earnings Outlook For Genmab
Get GENMAB A/S/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMXAY and its competitors with MarketBeat's FREE daily newsletter.

Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)

The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!

Get the name of the stock here >>>

GMXAY Media Mentions By Week

GMXAY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GMXAY
News Sentiment

0.00

0.76

Average
Medical
News Sentiment

GMXAY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GMXAY Articles
This Week

0

0

GMXAY Articles
Average Week

Get GENMAB A/S/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMXAY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:GMXAY) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners